Halbert Hargroverussell Lowers stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Halbert Hargroverussell reduced its stake in Thermo Fisher Scientific by 14.18% during the most recent quarter end. The investment management company now holds a total of 2,409 shares of Thermo Fisher Scientific which is valued at $356,267 after selling 398 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on May 12, 2016.Thermo Fisher Scientific makes up approximately 0.13% of Halbert Hargroverussell’s portfolio.

Other Hedge Funds, Including , Paradigm Asset Management Co boosted its stake in TMO in the latest quarter, The investment management firm added 51 additional shares and now holds a total of 551 shares of Thermo Fisher Scientific which is valued at $81,487. Thermo Fisher Scientific makes up approx 0.02% of Paradigm Asset Management Co’s portfolio.Pioneer Investment Management Inc boosted its stake in TMO in the latest quarter, The investment management firm added 110,697 additional shares and now holds a total of 2,353,745 shares of Thermo Fisher Scientific which is valued at $348.1 Million. Thermo Fisher Scientific makes up approx 1.34% of Pioneer Investment Management Inc’s portfolio. Ausdal Financial Partners sold out all of its stake in TMO during the most recent quarter. The investment firm sold 60 shares of TMO which is valued $8,818.Choate Investment Advisors reduced its stake in TMO by selling 1,524 shares or 31.94% in the most recent quarter. The Hedge Fund company now holds 3,247 shares of TMO which is valued at $477,212. Thermo Fisher Scientific makes up approx 0.03% of Choate Investment Advisors’s portfolio.Cryder Capital Partners Llp boosted its stake in TMO in the latest quarter, The investment management firm added 1,336 additional shares and now holds a total of 112,911 shares of Thermo Fisher Scientific which is valued at $16.3 Million. Thermo Fisher Scientific makes up approx 12.41% of Cryder Capital Partners Llp’s portfolio.

Thermo Fisher Scientific opened for trading at $149.35 and hit $150.31 on the upside on Friday, eventually ending the session at $148.85, with a gain of 0.29% or 0.43 points. The heightened volatility saw the trading volume jump to 14,20,931 shares. Company has a market cap of $58,574 M.

On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 19, 2016 to “Buy”, Firm has raised the Price Target to $ 166 from a previous price target of $163 .Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.